Elyara Dermal Fillers

Regenerative Dermal Fillers

Designed for Natural-Looking Results

Elyara Dermal Fillers combine peptide-integrated hyaluronic acid technology with regenerative science to support volume restoration, facial rejuvenation, and skin quality improvement. Developed for physician-led treatments, Elyara delivers immediate aesthetic enhancement while supporting long-term tissue regeneration and collagen production.

Elyara Dermal Filler Plus Elyara Dermal Filler Ultra

Beyond Filling.
Towards Regeneration.

Traditional dermal fillers restore lost volume. Elyara was developed to go further. By combining cross-linked hyaluronic acid with patented biomimetic peptides, Elyara is designed to support both immediate volumization and the biological processes associated with skin regeneration, collagen production, and long-term rejuvenation.

Volume Restoration

Immediate support for age-related structural changes and facial volume loss.

Facial Contouring

Defined shaping for physician-led facial rejuvenation and contour refinement.

Collagen Stimulation

Biomimetic peptides support pathways associated with collagen production.

Tissue Regeneration

Supports cellular activity involved in dermal renewal and tissue remodeling.

Skin Quality

Supports hydration, elasticity, firmness, and overall skin appearance.

Natural Movement

Designed to integrate with facial tissues while preserving expression and balance.

A Dual-Peptide
Regenerative Platform

At the core of Elyara is a patented peptide architecture designed to support filler longevity and tissue regeneration simultaneously.

CG-Boostrin

Supporting Longevity

A patented peptide designed to inhibit hyaluronidase activity and support filler stability within tissue.

  • Slower HA degradation
  • Enhanced longevity
  • Greater stability
  • Prolonged aesthetic outcomes

CG-Glamerin

Supporting Regeneration

A regenerative peptide designed to support collagen and elastin production.

  • Collagen synthesis
  • Elastin production
  • Skin firmness
  • Tissue remodeling

Technology

Peptide-Integrated HA

Cross-linked hyaluronic acid and biomimetic peptides combined in a single formulation.

Delivery

Double Encapsulation

Designed for controlled biological activity and improved formulation stability.

Standard

CE-Approved

Developed for physician-led aesthetic treatment protocols.

Supporting Facial Rejuvenation
Through Multiple Pathways

Elyara Dermal Fillers are designed to combine immediate volumization with regenerative support, addressing both structural correction and long-term skin quality.

Volume Restoration

Cross-linked hyaluronic acid provides immediate support for facial contours, volume loss, and age-related structural changes.

Collagen Support

Patented biomimetic peptides are designed to support biological pathways associated with collagen production and skin firmness.

Tissue Regeneration

Supports cellular activity involved in tissue remodeling and dermal renewal for improved skin quality over time.

Skin Quality Improvement

Supports hydration, elasticity, and overall skin appearance beyond volumization alone.

Natural Facial Movement

Designed to integrate with facial tissues while preserving natural expression, movement, and aesthetic balance.

One Regenerative
Philosophy

Backed by
Scientific Evaluation

Laboratory evaluations demonstrated positive upregulation of collagen production and hyaluronic acid synthesis in human fibroblast cells.

81%

Increase in collagen expression, supporting dermal remodeling and skin rejuvenation.

45%

Increase in hyaluronic acid production, supporting hydration and skin quality.

90%

Reduction in hyaluronidase activity, supporting filler longevity and resistance to degradation.

Strong

Antioxidant activity supporting protection against oxidative stress.

Results Supported by
Clinical Evaluation

A clinical evaluation involving 142 patients demonstrated high physician and patient satisfaction following treatment. A 99% positive outcome rate was observed, with no allergic reactions reported during the evaluation.

Wrinkle Reduction

Observed improvement in facial lines and folds.

Facial Contour Enhancement

Visible refinement across contour-focused treatment areas.

Volume Restoration

Support for age-related facial volume loss.

Lip Enhancement

Defined enhancement while supporting natural-looking outcomes.

Facial Rejuvenation

Overall aesthetic improvement across multiple treatment areas.

Before & After Areas

Nasolabial folds, mid-face volumization, cheek contouring, lips, and facial rejuvenation.

More Than a Product.
A Complete Support System.

Elyara supports clinics through education, treatment guidance, and patient engagement resources designed to help physicians integrate regenerative aesthetics into their practice.

Clinical Protocol Support

Structured resources for product selection, treatment planning, and protocol integration.

Educational Training

Training resources designed for physician-led regenerative aesthetic programs.

Patient Communication

Materials to help explain product positioning, treatment expectations, and outcomes.

In-Clinic Branding

Support assets designed for clinic environments and treatment education.

Social And Video Content

Social media content and professional video scripts for practice communication.

Clinical Experience Exchange

Support for sharing clinical learning and protocol development across practitioners.

Dermal Filler
Questions

What are Elyara Dermal Fillers?

Elyara Dermal Fillers are CE-approved peptide-integrated hyaluronic acid fillers designed to support volume restoration, facial contouring, collagen stimulation, and skin rejuvenation.

What makes Elyara different from traditional dermal fillers?

Unlike conventional fillers that primarily restore volume, Elyara combines hyaluronic acid with patented biomimetic peptides designed to support regenerative processes associated with collagen production and tissue renewal.

What is peptide-integrated hyaluronic acid technology?

This technology combines cross-linked hyaluronic acid with regenerative biomimetic peptides within a single formulation, creating a dual-action approach to volumization and rejuvenation.

What are CG-Boostrin and CG-Glamerin?

CG-Boostrin is designed to support filler longevity by helping reduce hyaluronidase activity, while CG-Glamerin is designed to support collagen and elastin production associated with skin rejuvenation.

What is the difference between Elyara Plus and Elyara Ultra?

Elyara Plus is designed for versatile facial rejuvenation and wrinkle correction, while Elyara Ultra is designed for deeper structural support, contouring, and facial sculpting.

Are Elyara Dermal Fillers CE-approved?

Yes. Elyara Dermal Fillers are CE-approved for physician-led aesthetic treatments.

What treatment areas can Elyara be used for?

Depending on product selection and physician assessment, Elyara may be used for cheeks, jawline, chin, lips, nasolabial folds, marionette lines, tear troughs, and facial contouring.

How long do Elyara Dermal Fillers last?

Treatment longevity varies based on patient characteristics, treatment area, injection technique, and product selection. Physicians can provide individualized guidance during consultation.

Who is an ideal candidate for Elyara Dermal Fillers?

Individuals seeking facial rejuvenation, contour enhancement, volume restoration, and natural-looking aesthetic outcomes may be suitable candidates following physician assessment.

How can physicians partner with Elyara?

Clinics and physicians can contact Elyara to learn more about product availability, training, clinical support, and partnership opportunities.

Bring Regenerative Aesthetics to Your Practice

Offer patients a next-generation dermal filler designed to combine immediate volumization with regenerative science.

Aesthetic & Dermatology Clinics

Integrate CE-approved peptide-integrated dermal fillers with product training, clinical resources, and protocol support.

Physician-Led Protocols

Support facial rejuvenation, contouring, and skin quality protocols with education and patient communication materials.

Regional Distributors

Discuss distribution opportunities for markets where demand for science-led injectable aesthetics is established.